Josh Gottheimer sold AbbVie Inc (NYSE: ABBV)
Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 20 trades in AbbVie Inc (ABBV) since 2022, 9 purchases and 11 sales, worth an estimated $160K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Josh Gottheimer sold $1,001 - $15,000 of AbbVie Inc (NYSE: ABBV) on February 7, 2023. Since that trade, ABBV is up +103.88% against the S&P 500 up +83.27%, an outperformance of +20.60%.
Across these filings, Josh Gottheimer has been a net seller of ABBV (a buy-to-sell ratio of 0.82). The most recent disclosed ABBV transaction shown was dated May 5, 2026. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Josh Gottheimer's ABBV trades vs the price
ABBV is up +103.88% since Josh Gottheimer sold on February 7, 2023, versus +83.27% for the S&P 500.
Performance since this trade
All Josh Gottheimer ABBV trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Josh Gottheimer & ABBV trading FAQ
Is it legal for Josh Gottheimer to trade AbbVie Inc (ABBV) stock?
Yes. Members of Congress are allowed to trade individual stocks, including AbbVie Inc (ABBV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Josh Gottheimer sell ABBV?
Josh Gottheimer disclosed a sale of $1,001 - $15,000 of AbbVie Inc (ABBV) on February 7, 2023, according to public STOCK Act filings.
How has ABBV performed since Josh Gottheimer's trade?
Since Josh Gottheimer sold ABBV on February 7, 2023, the stock is up +103.88%, versus +83.27% for the S&P 500 over the same period, an outperformance of +20.60%.
How many times has Josh Gottheimer traded ABBV?
Josh Gottheimer has disclosed 20 ABBV trades since 2022 (9 purchases and 11 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ABBV trades?
Quantellect tracks every disclosed congressional trade in AbbVie Inc (ABBV) on the AbbVie Inc congressional trading page, which aggregates filings across all members of Congress.
Josh Gottheimer's ABBV tradesAll congressional filings for AbbVie IncJosh Gottheimer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.